A drug trial failure this spring has had no impact on the market for one of Bristol Myers Squibb’s most closely-watched new ...

Bill Gates in 2024. Craig Barritt/Getty As Gates noted in his essay, more than 7 million people in the United States, or about 1 in 9 people over the age of 65, currently have Alzheimer’s disease.

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.

Alzheimer’s disease has become one of the most common and challenging illnesses facing aging population today. Approximately 6.9 million Americans aged 65 and older are currently living with the ...

5 Years After Dad's Alzheimer's Death, Bill Gates Is ‘Optimistic’ About 'Progress' Made in Fighting the Disease "We are closer than ever before to a world where no one has to watch someone ...

Bill Gates is speaking out about his personal experience with Alzheimer’s — and his hope for progress in fighting the disease. In an essay published this week on his blog at GatesNotes.com ...

Sadly, we lost my dad in 2020 to Alzheimer’s disease. Watching my brilliant, loving father go downhill and disappear was a brutal experience.

With the number of Americans living with the disease steadily increasing, scientists predict that 13.8 million will have Alzheimer’s by 2050, or 16% of the US population over the age of 65.

As we age, neurocognitive disorders, including dementia and Alzheimer’s disease, can be particularly worrisome, impacting not just the individual but also their loved ones. Understanding the ...

A cholinergic agonist first developed in the 1990s for Alzheimer’s disease, xanomeline, was approved last year in combination with trospium chloride, a side-effect blocker, for the treatment of ...

Dana Territo is an Alzheimer’s advocate and author of “What My Grandchildren Taught Me About Alzheimer’s Disease.” She hosts "The Memory Whisperer." Email her at thememorywhisperer@gmail.com.

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.